Join
Live feed
·
NEWSReleasevia Quantisnow
First Wave BioPharma Inc. logo

First Wave Biopharma Announced Research Generated From Two Previously Completed Phase 2 Clinical Trials Of Latiglutenase Has Been Published In The Special Issue In The Peer-reviewed Scientific Journal

ByQuantisnow·Wall Street's wire, on your screen.
FWBI· First Wave BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FWBI (First Wave BioPharma Inc.) and more on Quantisnow.